TerminatedNCT05118204
Study of Buprenorphine Microdose Inductions During Hospitalization
This study was terminated in the United States. It focuses on Addiction.
In United StatesAddictionBehavioralOver 18 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT02134691
Study of Prolonged Exposure for PTSD (PTSD)
This study is completed in the United States. It focuses on PTSD.
Broader resultPTSDBehavioralFrom 18 Years to 64 Years
CompletedNCT03092271
Study of Stepped Care for Suicide prevention in Teens and Young Adults
This study is completed in the United States. It focuses on Suicide prevention.
In United StatesSuicidalityBehavioralFrom 12 Years to 24 Years
CompletedNCT00328445
Study of the Positive Action Program in Hawaii Schools
This study is completed in the United States. It focuses on Addiction.
In United StatesAddictionBehavioralOver 6 Years
CompletedNCT05568901
Study to Improve Safe Firearm Storage
This study is completed in the United States. It focuses on Suicide prevention.
In United StatesSuicidalityBehavioral
CompletedNCT00645944
Controlled, Double Blind study of Eszopiclone for Insomnia Associated With Schizophrenia
This study is completed in the United States. It focuses on schizophrenia.
In United StatesSchizophreniaDrugA study involving a medication or substance.From 18 Years to 64 Years
CompletedNCT02109562
Safety study of Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in schizophrenia
This study is completed in the United States. It is testing Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 for schizophrenia.
In United StatesSchizophreniaDrugFrom 18 Years to 55 Years
TerminatedNCT06011577
Study of REL-1017 as Adjunctive Treatment for MDD
This study was terminated in the United States. It focuses on Depression.
In United StatesDepressionDrugFrom 18 Years to 65 Years
CompletedNCT06179108
Double-blinded, Evaluating the Treatment With LB-102 in people with Acute Schizophrenia
This study is completed in the United States. It focuses on schizophrenia.
In United StatesSchizophreniaDrugFrom 18 Years to 55 Years
CompletedNCT01449955
Rapamycin as a Means of Interference With Reconsolidation of PTSD-related Traumatic Memory
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesPTSDBehavioralOver 18 Years
WithdrawnNCT05100004
Rapid Acting TMS for Suicide Ideation in Depression
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesDepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 75 Years
Active Not RecruitingNCT04739969
Rapid Acting Transcranial Magnetic Stimulation
This study is looking at whether a digital support tool can help people with Treatment Resistant Depression. Participants take part in a digital support tool and complete follow-up assessments.
In United StatesDepressionDeviceFrom 22 Years to 65 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.